Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O Scheiner

Showing results (201-210 of 223) with videos related to

Pageof 23
Sort By:
International Archives of Allergy and Immunology|September 26, 1997
Inhibition of allergen-induced histamine release from human basophils by cyclosporine A and FK-506W R Sperr, H Agis, H Semper, et al.
International Archives of Allergy and Immunology|April 18, 2001
Rapid production of recombinant allergens in Nicotiana benthamiana and their impact on diagnosis and therapyH Breiteneder, M Krebitz, U Wiedermann, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|February 28, 2004
Allergen-loaded biodegradable poly(D,L-lactic-co-glycolic) acid nanoparticles down-regulate an ongoing Th2 response in the BALB/c mouse modelI Schöll, A Weissenböck, E Förster-Waldl, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|April 10, 2002
Cloning and molecular characterization of the Hevea brasiliensis allergen Hev b 11, a class I chitinaseG O'Riordain, C Radauer, K Hoffmann-Sommergruber, et al.
International Archives of Allergy and Immunology|September 8, 2007
Prevalence of IgE-binding to Art v 1, Art v 4 and Amb a 1 in mugwort-allergic patientsC Oberhuber, Y Ma, N Wopfner, et al.
International Immunology|February 18, 1998
Bet v 1, the major birch pollen allergen, conjugated to crystalline bacterial cell surface proteins, expands allergen-specific T cells of the Th1/Th0 phenotype in vitro by induction of IL-12B Jahn-Schmid, U Siemann, A Zenker, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|October 20, 2001
Monovalent fusion proteins of IgE mimotopes are safe for therapy of type I allergyE Ganglberger, Barbara Sponer, I Schöll, et al.
International Archives of Allergy and Immunology|February 17, 2005
In vitro analysis of birch-pollen-associated food allergy by use of recombinant allergens in the basophil activation testS M Erdmann, B Sachs, A Schmidt, et al.
Breast Cancer Research and Treatment|January 22, 2010
A virosomal formulated Her-2/neu multi-peptide vaccine induces Her-2/neu-specific immune responses in patients with metastatic breast cancer: a phase I studyUrsula Wiedermann, C Wiltschke, J Jasinska, et al.
Advances in Experimental Medicine and Biology|January 1, 1996
Isolation and cloning of Bet v 1-homologous food allergens from celeriac (Api g1) and apple (Mal d1)K Hoffmann-Sommergruber, M Vanek-Krebitz, R Ferris, et al.
Pageof 23

Showing results (201-210 of 223) with videos related to

Sort By:
Pageof 23
International Archives of Allergy and Immunology|September 26, 1997
Inhibition of allergen-induced histamine release from human basophils by cyclosporine A and FK-506W R Sperr, H Agis, H Semper, et al.
International Archives of Allergy and Immunology|April 18, 2001
Rapid production of recombinant allergens in Nicotiana benthamiana and their impact on diagnosis and therapyH Breiteneder, M Krebitz, U Wiedermann, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|February 28, 2004
Allergen-loaded biodegradable poly(D,L-lactic-co-glycolic) acid nanoparticles down-regulate an ongoing Th2 response in the BALB/c mouse modelI Schöll, A Weissenböck, E Förster-Waldl, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|April 10, 2002
Cloning and molecular characterization of the Hevea brasiliensis allergen Hev b 11, a class I chitinaseG O'Riordain, C Radauer, K Hoffmann-Sommergruber, et al.
International Archives of Allergy and Immunology|September 8, 2007
Prevalence of IgE-binding to Art v 1, Art v 4 and Amb a 1 in mugwort-allergic patientsC Oberhuber, Y Ma, N Wopfner, et al.
International Immunology|February 18, 1998
Bet v 1, the major birch pollen allergen, conjugated to crystalline bacterial cell surface proteins, expands allergen-specific T cells of the Th1/Th0 phenotype in vitro by induction of IL-12B Jahn-Schmid, U Siemann, A Zenker, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|October 20, 2001
Monovalent fusion proteins of IgE mimotopes are safe for therapy of type I allergyE Ganglberger, Barbara Sponer, I Schöll, et al.
International Archives of Allergy and Immunology|February 17, 2005
In vitro analysis of birch-pollen-associated food allergy by use of recombinant allergens in the basophil activation testS M Erdmann, B Sachs, A Schmidt, et al.
Breast Cancer Research and Treatment|January 22, 2010
A virosomal formulated Her-2/neu multi-peptide vaccine induces Her-2/neu-specific immune responses in patients with metastatic breast cancer: a phase I studyUrsula Wiedermann, C Wiltschke, J Jasinska, et al.
Advances in Experimental Medicine and Biology|January 1, 1996
Isolation and cloning of Bet v 1-homologous food allergens from celeriac (Api g1) and apple (Mal d1)K Hoffmann-Sommergruber, M Vanek-Krebitz, R Ferris, et al.
Pageof 23